US FDA approves Orca Bio's blood cancer therapy
جونسون آند جونسون
Incyte Corporation
آبفي
Johnson & Johnson JNJ | 0.00 | |
Incyte Corporation INCY | 0.00 | |
AbbVie, Inc. ABBV | 0.00 |
June 30 (Reuters) - The U.S. Food and Drug Administration has approved Orca Bio's cell therapy for the treatment of certain blood cancers, the regulator said on Tuesday.